Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip C Hoffman

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Hematology. American Society of Hematology. Education Program|November 25, 2006
Immune hemolytic anemia--selected topicsPhilip C Hoffman
Hematology. American Society of Hematology. Education Program|December 17, 2009
Immune hemolytic anemia--selected topicsPhilip C Hoffman
Clinical Advances in Hematology & Oncology : H&O|November 4, 2022
Serving on the FDA oncologic drugs advisory committeePhilip C Hoffman
Journal of Neurology Research|March 19, 2013
Temozolomide and/or Erlotinib in the Treatment of Lung Cancer Patients With Progressive Central Nervous System MetastasesRimas V Lukas, Martin Kelly Nicholas, Victoria Villaflor, et al.
Transfusion|August 16, 2003
Thrombotic thrombocytopenic purpura after cephalosporin administration: a possible relationshipBeverly W Baron, Koen van Besien, Philip C Hoffman, et al.
American Journal of Clinical Oncology|June 7, 2007
Chemotherapy and high dose radiotherapy followed by resection for locally advanced nonsmall cell lung cancersArif Y Shaikh, Daniel J Haraf, Joseph K Salama, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancerCharles M Rudin, Mark Kozloff, Philip C Hoffman, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2003
A phase II study of bryostatin-1 and paclitaxel in patients with advanced non-small cell lung cancerJerome D Winegarden, Ann M Mauer, Thomas F Gajewski, et al.
Clinical Lung Cancer|December 10, 2003
Phase I study of dose-dense alternating doublets in advanced non-small-cell lung cancerEverett E Vokes, Chaiyut Charoentum, Gary S Gordon, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2002
Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I studyPhilip C Hoffman, Ezra E W Cohen, Gregory A Masters, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Hematology. American Society of Hematology. Education Program|November 25, 2006
Immune hemolytic anemia--selected topicsPhilip C Hoffman
Hematology. American Society of Hematology. Education Program|December 17, 2009
Immune hemolytic anemia--selected topicsPhilip C Hoffman
Clinical Advances in Hematology & Oncology : H&O|November 4, 2022
Serving on the FDA oncologic drugs advisory committeePhilip C Hoffman
Journal of Neurology Research|March 19, 2013
Temozolomide and/or Erlotinib in the Treatment of Lung Cancer Patients With Progressive Central Nervous System MetastasesRimas V Lukas, Martin Kelly Nicholas, Victoria Villaflor, et al.
Transfusion|August 16, 2003
Thrombotic thrombocytopenic purpura after cephalosporin administration: a possible relationshipBeverly W Baron, Koen van Besien, Philip C Hoffman, et al.
American Journal of Clinical Oncology|June 7, 2007
Chemotherapy and high dose radiotherapy followed by resection for locally advanced nonsmall cell lung cancersArif Y Shaikh, Daniel J Haraf, Joseph K Salama, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancerCharles M Rudin, Mark Kozloff, Philip C Hoffman, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2003
A phase II study of bryostatin-1 and paclitaxel in patients with advanced non-small cell lung cancerJerome D Winegarden, Ann M Mauer, Thomas F Gajewski, et al.
Clinical Lung Cancer|December 10, 2003
Phase I study of dose-dense alternating doublets in advanced non-small-cell lung cancerEverett E Vokes, Chaiyut Charoentum, Gary S Gordon, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2002
Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I studyPhilip C Hoffman, Ezra E W Cohen, Gregory A Masters, et al.
Pageof 3